Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arevik Ghulakhszian

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Open|April 25, 2021
Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot studyJamie Enoch, Arevik Ghulakhszian, David P Crabb, et al.
Eye (London, England)|May 19, 2021
Intravitreal treatment for geographic atrophy: coming soon to a patient near you?Christiana Dinah, Jamie Enoch, Arevik Ghulakhszian, et al.
Eye (London, England)|May 11, 2023
Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: A mixed-methods studyJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
BMJ Open|January 18, 2024
Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional studyChristiana Dinah, Jamie Enoch, Arevik Ghulakhszian, et al.
Patient Preference and Adherence|February 9, 2023
Towards a Therapy for Geographic Atrophy: A Patient's ExperienceJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
BMC Research Notes|September 30, 2023
Piloting a forced-choice task to elicit treatment preferences in geographic atrophyJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
Research Involvement and Engagement|August 1, 2025
Implementing patient and public involvement (PPI) in eye research: reflections from developing a research study on Geographic Atrophy treatment acceptabilityJamie Enoch, David Matthews, Arevik Ghulakhszian, et al.
Plos One|February 11, 2021
Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West LondonChristiana Dinah, Arevik Ghulakhszian, Sing Yue Sim, et al.
Plos One|September 16, 2021
Correction: Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West LondonChristiana Dinah, Arevik Ghulakhszian, Sing Yue Sim, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 28, 2021
Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World StudySing Yue Sim, Arevik Ghulakhszian, Amal Minocha, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Open|April 25, 2021
Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot studyJamie Enoch, Arevik Ghulakhszian, David P Crabb, et al.
Eye (London, England)|May 19, 2021
Intravitreal treatment for geographic atrophy: coming soon to a patient near you?Christiana Dinah, Jamie Enoch, Arevik Ghulakhszian, et al.
Eye (London, England)|May 11, 2023
Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: A mixed-methods studyJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
BMJ Open|January 18, 2024
Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional studyChristiana Dinah, Jamie Enoch, Arevik Ghulakhszian, et al.
Patient Preference and Adherence|February 9, 2023
Towards a Therapy for Geographic Atrophy: A Patient's ExperienceJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
BMC Research Notes|September 30, 2023
Piloting a forced-choice task to elicit treatment preferences in geographic atrophyJamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, et al.
Research Involvement and Engagement|August 1, 2025
Implementing patient and public involvement (PPI) in eye research: reflections from developing a research study on Geographic Atrophy treatment acceptabilityJamie Enoch, David Matthews, Arevik Ghulakhszian, et al.
Plos One|February 11, 2021
Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West LondonChristiana Dinah, Arevik Ghulakhszian, Sing Yue Sim, et al.
Plos One|September 16, 2021
Correction: Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West LondonChristiana Dinah, Arevik Ghulakhszian, Sing Yue Sim, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 28, 2021
Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World StudySing Yue Sim, Arevik Ghulakhszian, Amal Minocha, et al.
Pageof 2